Measuring urinary N-acetyl-S-(4-hydroxy-2-methyl-2-buten-1-yl)-L-cysteine (IPMA3) as a potential biomarker of isoprene exposure

Analytica Chimica Acta

Volumn 941, Issue , 2016, Pages 61-66

  Alwis, K Udeni ^a   Bailey, T Liz ^a   Patel, Dhrusti ^a   Wang, Liqun ^a   Blount, Benjamin C ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Biomonitoring; Isoprene; Metabolism; Tobacco smoke; UPLC ESI MSMS; Urinary metabolites

Indexed keywords

AMINO ACIDS; BIOMARKERS; BIOMOLECULES; BODY FLUIDS; CHROMATOGRAPHY; DISEASES; ELECTROSPRAY IONIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INDOOR AIR POLLUTION; INTERNATIONAL COOPERATION; IONIZATION OF LIQUIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITES; SMOKE; TOBACCO;

ANTHROPOGENIC SOURCES; BIOMONITORING; INTERNATIONAL AGENCY FOR RESEARCH ON CANCERS; TANDEM MASS SPECTROMETRY; TOBACCO SMOKE; ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHIES; UPLC/ESI-MSMS; URINARY METABOLITES;

ISOPRENE;

BIOLOGICAL MARKER; CYSTEINE; ISOPRENE; N ACETYL(2 HYDROXY 3 METHYL 3 BUTEN 1 YL)CYSTEINE; N ACETYL(4 HYDROXY 2 METHYL 2 BUTEN 1 YL)CYSTEINE; N ACETYL[1 [HYDROXYMETHYL] 2 METHYL 2 PROPEN 1 YL]CYSTEINE; N ACETYL[2 HYDROXY 2 METHYL 3 BUTEN 1 YL]CYSTEINE; UNCLASSIFIED DRUG; 1,3 BUTADIENE DERIVATIVE; CARCINOGEN; HEMITERPENE; PENTANE;

ARTICLE; CONTROLLED STUDY; ELECTROSPRAY IONIZATION TRIPLE QUAD TANDEM MASS SPECTROMETRY; FREEZE THAWING; LIMIT OF DETECTION; PRIORITY JOURNAL; STORAGE TEMPERATURE; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINE LEVEL; URINE SAMPLING; HUMAN; URINALYSIS; URINE;

BIOMARKERS; BUTADIENES; CARCINOGENS; CYSTEINE; HEMITERPENES; HUMANS; LIMIT OF DETECTION; PENTANES; URINALYSIS;

EID: 84990064359     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2016.08.023     Document Type: Article

References (26)

1. [1] IARC, International Agency for Research on Cancer Monographs on the Evaluation of Carcinogenic Risks to Humans. Summaries and Evaluations: Isoprene (Group 2B). 1999, IARC, Lyon, France, 1015.
2. [2] IARC, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, VinylChloride and Vinyl Bromide) IARC, Lyon, France. 2008.
3. [3] NTP, National Toxicology Program, Report on Carcinogens., thirteenth ed., 2014, Dept. of Health and Human Services, 1–4 Isoprene (CAS No. 78-79-5).
4. [4] Taalman, R.D., Isoprene: background and issues. Toxicology 113 (1996), 242–246.
5. [5] Tambunan, P., Baba, S., Kuniyoshi, A., Iwasaki, H., Nakamura, T., Yamasaki, H., Oku, H., Isoprene emission from tropical trees in Okinawa Island, Japan. Chemosphere 65 (2006), 2138–2144.
6. [6] Haussmann, H.J., Use of hazard indices for a theoretical evaluation of cigarette smoke composition. Chem. Res. Toxicol. 25:4 (2012), 794–810.
7. [7] Roemer, E., Stabbert, R., Rustemeier, K., Veltel, D.J., Meisgen, T.J., Reininghaus, W., Carchman, R.A., Gaworski, C.L., Podraza, K.F., Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 195 (2004), 31–52.
8. [8] DHHS, U.S., Department of Health and Human Services. Children and Secondhand Smoke Exposure. Excerpts from the Health Consequences of Involuntary Exposure to Tobacco Smoke., 2006, Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA., U.S A Report of the Surgeon General.
9. [9] FDA, Federal Register. Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Established List. 2012, Food and Drug Administration, United States, 20034–20037.
10. [10] Gelmont, D., Stein, R.A., Mead, J.F., Isoprene-the main hydrocarbon in human breath. Biochem. Biophys. Res. Commun. 99 (1981), 1456–1460.
11. [11] Cailleux, A., Cogny, M., Allain, P., Blood isoprene concentrations in humans and in some animal species. Biochem. Med. Metab. Biol. 47 (1992), 157–160.
12. [12] Alkhouri, N., Singh, T., Alsabbagh, E., Guirguis, J., Chami, T., Hanouneh, I., Grove, D., Lopez, R., Dweik, R., Isoprene in the exhaled breath is a novel biomarker for advanced fibrosis in patients with chronic liver disease. A Pilot Study, Clin. Transl. Gastroenterol., 6, 2015, e112.
13. [13] Buszewski, B., Ulanowska, A., Ligor, T., Denderz, N., Amann, A., Analysis of exhaled breath from smokers, passive smokers and non-smokers by solid-phase microextraction gas chromatography/mass spectrometry. Biomed. Chromatogr. BMC 23 (2009), 551–556.
14. [14] Gervasi, P.G., Longo, V., Metabolism and mutagenicity of isoprene. Environ. Health Perspect. 86 (1990), 85–87.
15. [15] Bogaards, J.J., Venekamp, J.C., van Bladeren, P.J., The biotransformation of isoprene and the two isoprene monoepoxides by human cytochrome P450 enzymes, compared to mouse and rat liver microsomes. Chem. Biol. Interact. 102 (1996), 169–182.
16. [16] Bogaards, J.J., Freidig, A.P., van Bladeren, P.J., Prediction of isoprene diepoxide levels in vivo in mouse, rat and man using enzyme kinetic data in vitro and physiologically-based pharmacokinetic modelling. Chem. Biol. Interact. 138 (2001), 247–265.
17. [17] Golding, B.T., Cottrell, L., Mackay, D., Zhang, D., Watson, W.P., Stereochemical and kinetic comparisons of mono- and diepoxide formation in the in vitro metabolism of isoprene by liver microsomes from rats, mice, and humans. Chem. Res. Toxicol. 16 (2003), 933–944.
18. [18] Small, R.D., Golding, B.T., Watson, W.P., Species differences in the stereochemistry of the metabolism of isoprene in vitro. Xenobiotica 27 (1997), 1155–1164.
19. [19] Bogaards, J.J., Venekamp, J.C., Salmon, F.G., van Bladeren, P.J., Conjugation of isoprene monoepoxides with glutathione, catalyzed by alpha, mu, pi and theta-class glutathione S-transferases of rat and man. Chem. Biol. Interact. 117 (1999), 1–14.
20. [20] Alwis, K.U., Blount, B.C., Britt, A.S., Patel, D., Ashley, D.L., Simultaneous analysis of 28 urinary VOC metabolites using ultra high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (UPLC-ESI/MSMS). Anal. Chim. Acta 750 (2012), 152–160.
21. [21] Taylor, J.K., Quality Assurance of Chemical Measurements. 1987, Lewis Publishers, Boca raton, FL.
22. [22] Caudill, S.P., Schleicher, R.L., Pirkle, J.L., Multi-rule quality control for the age-related eye disease study. Stat. Med. 27 (2008), 4094–4106.
23. [23] Richardson, K.A., Peters, M.M., Wong, B.A., Megens, R.H., van Elburg, P.A., Booth, E.D., Boogaard, P.J., Bond, J.A., Medinsky, M.A., Watson, W.P., van Sittert, N.J., Quantitative and qualitative differences in the metabolism of 14C-1,3-butadiene in rats and mice: relevance to cancer susceptibility. Toxicol. Sci. 49 (1999), 186–201.
24. [24] Elfarra, A.A., Sharer, J.E., Duescher, R.J., Synthesis and characterization of N-acetyl-L-cysteine S-conjugates of butadiene monoxide and their detection and quantitation in urine of rats and mice given butadiene monoxide. Chem. Res. Toxicol. 8 (1995), 68–76.
25. [25] Sharer, J.E., Duescher, R.J., Elfarra, A.A., Formation, stability, and rearrangements of the glutathione conjugates of butadiene monoxide: evidence for the formation of stable sulfurane intermediates. Chem. Res. Toxicol. 4 (1991), 430–436.
26. [26] Sharer, J.E., Duescher, R.J., Elfarra, A.A., Species and tissue differences in the microsomal oxidation of 1,3-butadiene and the glutathione conjugation of butadiene monoxide in mice and rats. Possible role in 1,3-butadiene-induced toxicity. Drug Metab. Dispos. 20 (1992), 658–664.